Photodynamic therapy for chronic central serous chorioretinopathy. - Wikidata - wikimedia - TriplyDB

Photodynamic therapy for chronic central serous chorioretinopathy.

Photodynamic therapy for chronic central serous chorioretinopathy.

http://www.wikidata.org/entity/Q33196510

about

Interventions for central serous chorioretinopathy: a network meta-analysis Interventions for central serous chorioretinopathy: a network meta-analysis Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study Ocular photodynamic therapy--standard applications and new indications. Part 2. Review of the literature and personal experience.Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results.[Therapy options for chronic central serous chorioretinopathy. Photodynamic therapy combined with bevacizumab - a case series].Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.Diagnosis and interventions for central serous chorioretinopathy: review and update.Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study.The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.Central serous chorioretinopathy: update on pathophysiology and treatment.Acute visual loss induced by dexamethasone during neoadjuvant docetaxol.System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy.Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy.Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.Intravitreal bevacizumab for treatment of refractory central serous choroidoretinopathy Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.Therapeutic benefit of melatonin in refractory central serous chorioretinopathy Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy.Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

P2860

Q24186996-6B008B21-ECDE-40FC-91F0-3F4A868E9D28 Q24188115-B9E8B0B2-09CB-4805-B8D8-A4BDE25D6D8A Q26824756-C1C81939-47D7-4E08-AA9E-FA2EEED2F013 Q31112014-9E0EE660-C337-4E82-AA46-ECCAA686920C Q33239033-CC3A6EF1-4C78-40E4-AF16-E32D4FBFB15B Q33295490-1882991F-9637-497A-9D36-6AC3A2CEF8BE Q33705962-FC686DDD-27A0-4835-8DB8-3036F8154672 Q33996055-6D285B0A-5ABD-4C35-983C-DC06B9EDF961 Q34076295-693BA8A7-CFC8-4D2E-B49D-8A010D4FF581 Q34210541-E9DE3853-F5A9-4851-8537-7DCDA76A6008 Q34325619-67F606A8-1A31-4319-B902-44E438554F08 Q34334335-54E22269-5477-40AA-89C3-C95480D08204 Q34334673-0ABADB32-FC7D-4797-A8E0-B954C2F235ED Q34338611-DBD4DA94-F400-4CFF-88D6-42852EB3510D Q34394791-443AB918-6C4D-4F2A-BFCD-BF858A67AF5D Q34587658-B8779284-30E6-4594-96D5-E14991AE515D Q35180971-F1226821-1B99-453C-8708-3BE4D5C05319 Q35209632-D6FE2DA5-10EE-4CD3-B975-480744351ED5 Q35561222-BFA61227-B203-4734-95E4-28D6FB408BCA Q35567966-354D3CB2-32E9-4156-BD86-B13DCDB76002 Q35593119-7ED228E6-E9D5-4EDE-9E6A-942F27B75F38 Q35826493-0F821C08-9AA4-42AF-8A38-EE2465488628 Q35886959-C5FB3F36-1F1D-43C7-8ED1-7B5194565635 Q35906128-A5887E72-99BE-4D8D-B190-7A55454B83DB Q35955614-EF09E7DE-A338-4D4E-BE15-81D9D886BC03 Q35970032-45B1BE65-598B-4C9E-8CBF-854808B7B6D7 Q36071607-470897C3-1907-41AE-9701-A907771E0DB0 Q36123646-680B93E0-FBE4-47DC-A6A7-4A9CC00252B6 Q36135515-86F7CA39-22CD-40B7-A5E6-F55499CCEAC4 Q36326807-F642291E-BA19-41BA-855F-FFF4FB8ADA07 Q36379671-B9F57864-A7E6-444B-9326-77061DA056A4 Q36407625-3D20F6CF-418A-452B-B013-645789F006F8 Q36516474-CA7A08C6-BAC3-4A48-96EC-4CB99568AAEC Q36685428-7FB95FF1-E747-4A6A-9A66-4319A2309C04 Q36685488-A147C0DE-3CB2-4CB7-AA47-4F69BE482367 Q37478532-AB2A712F-C12B-4C96-BAF1-2C57D031EB01 Q37667426-104383C4-A6AC-4B77-9346-613C20DB9A50 Q37949217-0DC77788-1648-4B9C-8501-C3D93AFD0372 Q38025702-4F8D2DBB-E3D8-4B93-B8C4-4B41EA2659F6 Q38160720-E881D16D-1C61-4BE8-B69D-5F74239FB300

P2860

Photodynamic therapy for chronic central serous chorioretinopathy.

http://www.wikidata.org/entity/Q33196510

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Photodynamic therapy for chronic central serous chorioretinopathy.

@ast

Photodynamic therapy for chronic central serous chorioretinopathy.

@en

type

label

Photodynamic therapy for chronic central serous chorioretinopathy.

@ast

Photodynamic therapy for chronic central serous chorioretinopathy.

@en

prefLabel

Photodynamic therapy for chronic central serous chorioretinopathy.

@ast

Photodynamic therapy for chronic central serous chorioretinopathy.

@en

P1433

Q33196510-EA1D7B90-986E-4B87-8C53-F82182CDA753

P1476

Q33196510-E0402459-6987-44F8-9676-AC49E92C9EA4

P2093

Q33196510-1F785CD8-446D-48CD-954A-5A16A1F1C5AD

Q33196510-32E50C64-70EA-4F3D-A1E4-28E60F147A0A

Q33196510-3D77CBB6-9B02-4404-B113-E09F59DED78F

Q33196510-4FAFB2E7-1526-496B-8EB3-71849E0A2FEE

Q33196510-EE8CD2A7-83E5-4DD4-94A9-577C5AEAE509

P304

Q33196510-2D25F737-765E-4045-AE86-8932CAA4CCDF

P31

Q33196510-7E3E3F11-DFF0-437E-B4A7-3F5B9DF46E20

P356

Q33196510-98206963-1168-488B-83E9-8B7CB8F45BA5

P433

Q33196510-0CF2CCF7-D825-4BD2-AB07-596439F8B72B

P478

Q33196510-381CB6C9-6897-416D-97A8-934B3C65B00C

P577

Q33196510-877B337F-B6E0-4A24-9967-71AD3B1B2B4B

P698

Q33196510-040E70BF-B958-4E4C-ADBF-B3ADAE63FC8D

P356

00006982-200312000-00002

P1433

P1476

Photodynamic therapy for chronic central serous chorioretinopathy.

@en

P2093

Chiara M Eandi

http://www.w3.org/2001/XMLSchema#string

Federico M Grignolo

http://www.w3.org/2001/XMLSchema#string

Felice Cardillo Piccolino

http://www.w3.org/2001/XMLSchema#string

Luca Ventre

http://www.w3.org/2001/XMLSchema#string

Roberta C Rigault de la Longrais

http://www.w3.org/2001/XMLSchema#string

P304

752-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00006982-200312000-00002

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14707823

http://www.w3.org/2001/XMLSchema#string